Skip to main content

Advertisement

Log in

Reactive Arthritis: Developments and Challenges in Diagnosis and Treatment

  • SERONEGATIVE ARTHRITIS (MA KHAN, SECTION EDITOR)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Reactive arthritis (ReA) has traditionally been described as a nonseptic arthritis occurring in the joint following an extra-articular bacterial infection. This concept became clinically associated with antecedent infections of either the gastrointestinal or genitourinary tract. Yet this operational definition of ReA has led to diagnostic uncertainty in different clinical settings. There are several scenarios in which the ReA has been complex. One is in the SAPHO syndrome, which shares many features with ReA. Another is the development of arthritis after infection with atypical organisms such as Clostridium difficile and Giardia lamblia. Treatment of ReA remains an area of ongoing investigation. There has been a randomized controlled trial of combination antibiotics in Chlamydia-induced ReA, which reported a positive result. There are several uncontrolled reports of anti-TNF agents being used successfully in refractory ReA. These studies in treatment modalities require validation on larger samples but do provide some encouraging preliminary findings from which to develop new therapeutic approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as:• Of importance

  1. Sieper J. Pathogenesis of reactive arthritis. Curr Rheumatol Rep. 2001;3(5):412.

    Article  PubMed  CAS  Google Scholar 

  2. Braun J, Kingsley G, van der Heijde D, Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3. J Rheumatol. 2000;27(9):2185.

    PubMed  CAS  Google Scholar 

  3. Earwaker JW, Cotton A. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol. 2003;32(6):311–27. Epub 2003 Apr 29.

    Article  PubMed  CAS  Google Scholar 

  4. Rosner I. SAPHO: disease, syndrome, or category? J Clin Rheumatol. 2002;8(1):3.

    Article  PubMed  Google Scholar 

  5. Govoni M, Colina M, Massara A, Trotta F. SAPHO syndrome and infections. Autoimmun Rev. 2009;8(3):256–9. Epub 2008 Aug 20.

    Article  PubMed  CAS  Google Scholar 

  6. Trimble BS, Evers CJ, Ballaron SA, Young JM. Intraarticular injection of Propionibacterium acnes causes an erosive arthritis in rats. Agent Actions. 1987;21(3–4):281–3.

    Article  CAS  Google Scholar 

  7. • Assmann G, Kueck O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, Zeidler H, Wagner AD. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther. 2009;11:R140. This study examines the evidence for the use of antibiotics in SAPHO syndrome and follow-up after discontinuance.

    Article  PubMed  Google Scholar 

  8. Rohekar G, Inman RD. Conundrums in nosology: synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and spondylarthritis. Arthritis Rheum. 2006;55(4):665–9.

    Article  PubMed  CAS  Google Scholar 

  9. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171(5):466–7.

    Article  PubMed  Google Scholar 

  10. Jacobs A, Barnard K, Fishel R, Gradon JD. Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature. Medicine (Baltimore). 2001;80(2):88–101.

    Article  CAS  Google Scholar 

  11. Cantey PT, Roy S, Lee B, Cronquist A, Smith K, Liang J, Beach MJ. Study of nonoutbreak giardiasis: novel findings and implications for research. Am J Med. 2011;124(12):1175.e1-8. Epub 2011 Oct 18.

    Article  PubMed  Google Scholar 

  12. Layton MA, Dziedzic K, Dawes PT. Sacroiliitis in an HLA B27-negative patient following giardiasis. Br J Rheumatol. 1998;37(5):581–3.

    Article  PubMed  CAS  Google Scholar 

  13. Gérard HC, Schumacher HR, El-Gabalawy H, Goldbach-Mansky R, Hudson AP. Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb Pathog. 2000;29(1):17–24.

    Article  PubMed  Google Scholar 

  14. Sarakbi HA, Hammoudeh M, Kanjar I, Al-Emadi S, Mahdy S, Siam A. Poststreptococcal reactive arthritis and the association with tendonitis, tenosynovitis, and enthesitis. J Clin Rheumatol. 2010;16(1):3–6.

    Article  PubMed  Google Scholar 

  15. Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford). 2004;43:949–54.

    Article  CAS  Google Scholar 

  16. • Carter JD, Espinoza LR, Inman RD, Sneed KB, Ricca LR, Vasey FB, Valeriano J, Stanich JA, Oszust C, Gerard HC, Hudson AP. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum. 2010;62(5):1298–307. This is the first randomized, placebo-controlled trial of combination antibiotics in Chlamydia-induced ReA and provides supportive evidence for antibiotic efficacy.

    Article  PubMed  CAS  Google Scholar 

  17. Leirisalo-Repo M. Prognosis, course of disease, and treatment of the spondyloarthropathies. Rheum Dis Clin N Am. 1998;24(4):737–51. viii.

    Article  CAS  Google Scholar 

  18. Flagg SD, Meador R, Hsia E, Kitumnuaypong T, Schumacher Jr HR. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthritis Rheum. 2005;53(4):613–7.

    Article  PubMed  CAS  Google Scholar 

  19. • Meyer A, Chatelus E, Wendling D, Berthelot JM, Dernis E, Houvenagel E, Morel J, Richer O, Schaeverbeke T, Gottenberg JE, Sibilia J, Club Rhumatisme et Inflammation. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. Arthritis Rheum. 2011;63(5):1274–80. This is the largest recent experience with anti-TNF agents in ReA and supports the concept of the safety and efficacy of these agents in refractory ReA.

    Article  PubMed  CAS  Google Scholar 

  20. Oili KS, Niinisalo H, Korpilähde T, Virolainen J. Treatment of reactive arthritis with infliximab. Scand J Rheumatol. 2003;32(2):122–4.

    Article  PubMed  Google Scholar 

  21. Gaylis N. Infliximab in the treatment of an HIV positive patient with Reiter’s syndrome. J Rheumatol. 2003;30(2):407–11.

    PubMed  Google Scholar 

  22. Gill H, Majithia V. Successful use of infliximab in the treatment of Reiter’s syndrome: a case report and discussion. Clin Rheumatol. 2008;27(1):121–3.

    Article  PubMed  Google Scholar 

  23. Abdelmoula LC, Yahia CB, Testouri N, Tekaya R, Ben M’barek R, Chaabouni L, Zouari R. Treatment of reactive arthritis with infliximab. Tunis Med. 2008;86(12):1095–7.

    PubMed  Google Scholar 

  24. Schafranski MD. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatol Int. 2010;30(5):679–80.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

Dr. Morris has no disclosures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert D. Inman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morris, D., Inman, R.D. Reactive Arthritis: Developments and Challenges in Diagnosis and Treatment. Curr Rheumatol Rep 14, 390–394 (2012). https://doi.org/10.1007/s11926-012-0280-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-012-0280-4

Keywords

Navigation